Next Article in Journal
Effect of Transportation and Pre-Slaughter Handling on Welfare and Meat Quality of Cattle: Case Study of Kumasi Abattoir, Ghana
Previous Article in Journal
Fatal Canine Leptospirosis on St. Kitts
Article Menu

Export Article

Open AccessArticle
Vet. Sci. 2014, 1(3), 159-173; doi:10.3390/vetsci1030159

Preliminary Metabolism of Lomustine in Dogs and Comparative Cytotoxicity of Lomustine and Its Major Metabolites in Canine Cells

1
Department of Comparative Biosciences, College of Veterinary Medicine, University of Illinois, Urbana, IL 61802, USA
2
Department of Veterinary Clinical Medicine, College of Veterinary Medicine, University of Illinois, Urbana, IL 61802, USA
*
Author to whom correspondence should be addressed.
Received: 7 August 2014 / Revised: 29 September 2014 / Accepted: 20 October 2014 / Published: 4 November 2014
View Full-Text   |   Download PDF [20614 KB, uploaded 5 November 2014]   |  

Abstract

The nitrosourea drug lomustine is used clinically for treating a wide variety of malignancies, most commonly brain tumors and lymphoma. Lomustine undergoes hydrolysis in vivo to form isomeric metabolites, primarily trans-4-hydroxylomustine (trans-4) and cis-4-hydroxylomustine (cis-4) in various animal species including humans. Despite its widespread usage to treat canine lymphoma, the metabolism of lomustine has not been studied in dogs. It is reported that 4'-hydroxylation products of lomustine (trans-4 and cis-4) have enhanced alkylating activity and reduced toxic effects relative to lomustine, resulting in a better therapeutic index of each of the metabolites relative to the parent compound. Our results show that the metabolic profile of lomustine in dogs is similar to that in humans with trans-4 being the major metabolite and cis-4 as the minor metabolite. Comparative cytotoxicity studies of lomustine and its trans-4 and cis-4 metabolites in canine lymphoma cell lines 17–71 and GL-1 show that there is no difference in the cytotoxicity of the three compounds. In addition, a concentration and time-dependent cell killing was seen in both of these cell lines. Also, primary canine cells like peripheral blood mononuclear cells (PBMC) from lymphoma dogs did not show any sensitivity towards lomustine and its metabolites. View Full-Text
Keywords: Lomustine; trans-4-hydroxylomustine; cis-4-hydroxylomustine; lymphoma; cytotoxicity Lomustine; trans-4-hydroxylomustine; cis-4-hydroxylomustine; lymphoma; cytotoxicity
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Chakkath, T.; Lavergne, S.N.; Fan, T.M.; Bunick, D.; Dirikolu, L. Preliminary Metabolism of Lomustine in Dogs and Comparative Cytotoxicity of Lomustine and Its Major Metabolites in Canine Cells. Vet. Sci. 2014, 1, 159-173.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Vet. Sci. EISSN 2306-7381 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top